Basal Insulin (Long-Acting Insulin) Market Report

China Basal Insulin (Long-Acting Insulin) Industry Market Research Report 2023-2029

  • POSTDATE：Sep 11, 2023
  • PAGES：206
  • REPORT CODE：GMM1793072
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Basal Insulin (Long-Acting Insulin) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Exir

    • Wockhardt

    • SEDICO

    • Novo Nordisk AS

    • Biocon

    • Eli Lilly

    • Julphar

    By Type:

    • Levemir

    • Basaglar

    • Toujeo

    • Tresiba

    • Insulin Glargine Biosimilars

    • Lantus

    By Application:

    • Type 2 Diabetes

    • Type 1 Diabetes

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Basal Insulin (Long-Acting Insulin) Market Overview 2018-2029

    • 1.1 China Basal Insulin (Long-Acting Insulin) Industry Development Overview

    • 1.2 China Basal Insulin (Long-Acting Insulin) Industry Development History

    • 1.3 China Basal Insulin (Long-Acting Insulin) Industry Market Size (2018-2029)

    • 1.4 China Basal Insulin (Long-Acting Insulin) Market Analysis by Type from Production Side

      • 1.4.1 China Basal Insulin (Long-Acting Insulin) Production Volume, Production Value and Growth Rate of Levemir (2018-2029)

      • 1.4.2 China Basal Insulin (Long-Acting Insulin) Production Volume, Production Value and Growth Rate of Basaglar (2018-2029)

      • 1.4.3 China Basal Insulin (Long-Acting Insulin) Production Volume, Production Value and Growth Rate of Toujeo (2018-2029)

      • 1.4.4 China Basal Insulin (Long-Acting Insulin) Production Volume, Production Value and Growth Rate of Tresiba (2018-2029)

      • 1.4.5 China Basal Insulin (Long-Acting Insulin) Production Volume, Production Value and Growth Rate of Insulin Glargine Biosimilars (2018-2029)

      • 1.4.6 China Basal Insulin (Long-Acting Insulin) Production Volume, Production Value and Growth Rate of Lantus (2018-2029)

    • 1.5 China Basal Insulin (Long-Acting Insulin) Market Analysis by Application from Consumption End

      • 1.5.1 China Basal Insulin (Long-Acting Insulin) Sales Volume, Sales Value and Growth Rate of Type 2 Diabetes (2018-2029)

      • 1.5.2 China Basal Insulin (Long-Acting Insulin) Sales Volume, Sales Value and Growth Rate of Type 1 Diabetes (2018-2029)

    • 1.6 China Basal Insulin (Long-Acting Insulin) Market Analysis by Region

      • 1.6.1 North China Basal Insulin (Long-Acting Insulin) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Basal Insulin (Long-Acting Insulin) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Basal Insulin (Long-Acting Insulin) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Basal Insulin (Long-Acting Insulin) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Basal Insulin (Long-Acting Insulin) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Basal Insulin (Long-Acting Insulin) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Basal Insulin (Long-Acting Insulin) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Basal Insulin (Long-Acting Insulin) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Basal Insulin (Long-Acting Insulin) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Basal Insulin (Long-Acting Insulin) Market Status and Competition Analysis in 2023

      • 2.2.3 China Basal Insulin (Long-Acting Insulin) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Basal Insulin (Long-Acting Insulin) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Basal Insulin (Long-Acting Insulin) Industry Development

    Chapter 3 Basal Insulin (Long-Acting Insulin)Industry Chain Analysis

    • 3.1 Basal Insulin (Long-Acting Insulin) Industry Chain

    • 3.2 Basal Insulin (Long-Acting Insulin) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Basal Insulin (Long-Acting Insulin) Market

    • 3.3 Basal Insulin (Long-Acting Insulin) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Basal Insulin (Long-Acting Insulin) Market

    Chapter 4 China Basal Insulin (Long-Acting Insulin) Market, by Type

    • 4.1 China Basal Insulin (Long-Acting Insulin) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Basal Insulin (Long-Acting Insulin) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Basal Insulin (Long-Acting Insulin) Production Volume and Growth Rate, by Type

      • 4.5.1 China Basal Insulin (Long-Acting Insulin) Production Volume and Growth Rate of Levemir

      • 4.5.2 China Basal Insulin (Long-Acting Insulin) Production Volume and Growth Rate of Basaglar

      • 4.5.3 China Basal Insulin (Long-Acting Insulin) Production Volume and Growth Rate of Toujeo

      • 4.5.4 China Basal Insulin (Long-Acting Insulin) Production Volume and Growth Rate of Tresiba

      • 4.5.5 China Basal Insulin (Long-Acting Insulin) Production Volume and Growth Rate of Insulin Glargine Biosimilars

      • 4.5.6 China Basal Insulin (Long-Acting Insulin) Production Volume and Growth Rate of Lantus

    Chapter 5 China Basal Insulin (Long-Acting Insulin) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Basal Insulin (Long-Acting Insulin) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Basal Insulin (Long-Acting Insulin) Market Size and Growth Rate, by Application

      • 5.5.1 China Basal Insulin (Long-Acting Insulin) Market Size and Growth Rate of Type 2 Diabetes

      • 5.5.2 China Basal Insulin (Long-Acting Insulin) Market Size and Growth Rate of Type 1 Diabetes

    Chapter 6 China Basal Insulin (Long-Acting Insulin) Market, by Region

    • 6.1 China Basal Insulin (Long-Acting Insulin) Production Volume and Production Value, by Region

    • 6.2 China Basal Insulin (Long-Acting Insulin) Sales Volume and Sales Value, by Region

    Chapter 7 North China Basal Insulin (Long-Acting Insulin) Market Analysis

    • 7.1 North China Basal Insulin (Long-Acting Insulin) Market, by Type

    • 7.2 North China Basal Insulin (Long-Acting Insulin) Market, by Application

    Chapter 8 Central China Basal Insulin (Long-Acting Insulin) Market Analysis

    • 8.1 Central China Basal Insulin (Long-Acting Insulin) Market, by Type

    • 8.2 Central China Basal Insulin (Long-Acting Insulin) Market, by Application

    Chapter 9 South China Basal Insulin (Long-Acting Insulin) Market Analysis

    • 9.1 South China Basal Insulin (Long-Acting Insulin) Market, by Type

    • 9.2 South China Basal Insulin (Long-Acting Insulin) Market, by Application

    Chapter 10 East China Basal Insulin (Long-Acting Insulin) Market Analysis

    • 10.1 East China Basal Insulin (Long-Acting Insulin) Market, by Type

    • 10.2 East China Basal Insulin (Long-Acting Insulin) Market, by Application

    Chapter 11 Northeast China Basal Insulin (Long-Acting Insulin) Market Analysis

    • 11.1 Northeast China Basal Insulin (Long-Acting Insulin) Market, by Type

    • 11.2 Northeast China Basal Insulin (Long-Acting Insulin) Market, by Application

    Chapter 12 Southwest China Basal Insulin (Long-Acting Insulin) Market Analysis

    • 12.1 Southwest China Basal Insulin (Long-Acting Insulin) Market, by Type

    • 12.2 Southwest China Basal Insulin (Long-Acting Insulin) Market, by Application

    Chapter 13 Northwest China Basal Insulin (Long-Acting Insulin) Market Analysis

    • 13.1 Northwest China Basal Insulin (Long-Acting Insulin) Market, by Type

    • 13.2 Northwest China Basal Insulin (Long-Acting Insulin) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Exir

        • 14.1.1 Exir Company Profile

        • 14.1.2 Exir Basal Insulin (Long-Acting Insulin) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Wockhardt

        • 14.2.1 Wockhardt Company Profile

        • 14.2.2 Wockhardt Basal Insulin (Long-Acting Insulin) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 SEDICO

        • 14.3.1 SEDICO Company Profile

        • 14.3.2 SEDICO Basal Insulin (Long-Acting Insulin) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Novo Nordisk AS

        • 14.4.1 Novo Nordisk AS Company Profile

        • 14.4.2 Novo Nordisk AS Basal Insulin (Long-Acting Insulin) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Biocon

        • 14.5.1 Biocon Company Profile

        • 14.5.2 Biocon Basal Insulin (Long-Acting Insulin) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Eli Lilly

        • 14.6.1 Eli Lilly Company Profile

        • 14.6.2 Eli Lilly Basal Insulin (Long-Acting Insulin) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Julphar

        • 14.7.1 Julphar Company Profile

        • 14.7.2 Julphar Basal Insulin (Long-Acting Insulin) Market Performance

        • 14.7.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Basal Insulin (Long-Acting Insulin) Industry Research Conclusions

    • 15.2 Basal Insulin (Long-Acting Insulin) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Basal Insulin (Long-Acting Insulin) Industry Market Size (2018-2029)

    • Figure China Basal Insulin (Long-Acting Insulin) Production Volume, Production Value and Growth Rate of Levemir (2018-2029)

    • Figure China Basal Insulin (Long-Acting Insulin) Production Volume, Production Value and Growth Rate of Basaglar (2018-2029)

    • Figure China Basal Insulin (Long-Acting Insulin) Production Volume, Production Value and Growth Rate of Toujeo (2018-2029)

    • Figure China Basal Insulin (Long-Acting Insulin) Production Volume, Production Value and Growth Rate of Tresiba (2018-2029)

    • Figure China Basal Insulin (Long-Acting Insulin) Production Volume, Production Value and Growth Rate of Insulin Glargine Biosimilars (2018-2029)

    • Figure China Basal Insulin (Long-Acting Insulin) Production Volume, Production Value and Growth Rate of Lantus (2018-2029)

    • Figure China Basal Insulin (Long-Acting Insulin) Sales Volume, Sales Value and Growth Rate of Type 2 Diabetes (2018-2029)

    • Figure China Basal Insulin (Long-Acting Insulin) Sales Volume, Sales Value and Growth Rate of Type 1 Diabetes (2018-2029)

    • Figure North China Basal Insulin (Long-Acting Insulin) Market Size and Growth Rate from 2018-2029

    • Figure Central China Basal Insulin (Long-Acting Insulin) Market Size and Growth Rate from 2018-2029

    • Figure South China Basal Insulin (Long-Acting Insulin) Market Size and Growth Rate from 2018-2029

    • Figure East China Basal Insulin (Long-Acting Insulin) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Basal Insulin (Long-Acting Insulin) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Basal Insulin (Long-Acting Insulin) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Basal Insulin (Long-Acting Insulin) Market Size and Growth Rate from 2018-2029

    • Figure Basal Insulin (Long-Acting Insulin) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Basal Insulin (Long-Acting Insulin) Market Share by Type in 2018

    • Figure China Basal Insulin (Long-Acting Insulin) Market Share by Type in 2023

    • Figure China Basal Insulin (Long-Acting Insulin) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Basal Insulin (Long-Acting Insulin) Production Volume and Growth Rate of Levemir (2018-2023)

    • Figure China Basal Insulin (Long-Acting Insulin) Production Volume and Growth Rate of Basaglar (2018-2023)

    • Figure China Basal Insulin (Long-Acting Insulin) Production Volume and Growth Rate of Toujeo (2018-2023)

    • Figure China Basal Insulin (Long-Acting Insulin) Production Volume and Growth Rate of Tresiba (2018-2023)

    • Figure China Basal Insulin (Long-Acting Insulin) Production Volume and Growth Rate of Insulin Glargine Biosimilars (2018-2023)

    • Figure China Basal Insulin (Long-Acting Insulin) Production Volume and Growth Rate of Lantus (2018-2023)

    • Figure China Basal Insulin (Long-Acting Insulin) Market Share by Application in 2018

    • Figure China Basal Insulin (Long-Acting Insulin) Market Share by Application in 2023

    • Figure China Basal Insulin (Long-Acting Insulin) Total Market Size and Growth Rate from Consumption End

    • Figure China Basal Insulin (Long-Acting Insulin) Market Size and Growth Rate of Type 2 Diabetes (2018-2023)

    • Figure China Basal Insulin (Long-Acting Insulin) Market Size and Growth Rate of Type 1 Diabetes (2018-2023)

    • Table China Basal Insulin (Long-Acting Insulin) Production Volume by Region (2018-2023)

    • Table China Basal Insulin (Long-Acting Insulin) Production Volume Share by Region (2018-2023)

    • Figure China Basal Insulin (Long-Acting Insulin) Production Volume Share by Region (2018-2023)

    • Table China Basal Insulin (Long-Acting Insulin) Production Value by Region (2018-2023)

    • Table China Basal Insulin (Long-Acting Insulin) Production Value Share by Region (2018-2023)

    • Figure China Basal Insulin (Long-Acting Insulin) Production Value Share by Region (2018-2023)

    • Table China Basal Insulin (Long-Acting Insulin) Sales Volume by Region (2018-2023)

    • Table China Basal Insulin (Long-Acting Insulin) Sales Volume Share by Region (2018-2023)

    • Figure China Basal Insulin (Long-Acting Insulin) Sales Volume Share by Region (2018-2023)

    • Table China Basal Insulin (Long-Acting Insulin) Sales Value by Region (2018-2023)

    • Table China Basal Insulin (Long-Acting Insulin) Sales Value Share by Region (2018-2023)

    • Figure China Basal Insulin (Long-Acting Insulin) Sales Value Share by Region (2018-2023)

    • Table North China Basal Insulin (Long-Acting Insulin) Production Volume by Type (2018-2023)

    • Table North China Basal Insulin (Long-Acting Insulin) Production Volume Share by Type (2018-2023)

    • Figure North China Basal Insulin (Long-Acting Insulin) Production Volume Share by Type (2018-2023)

    • Table North China Basal Insulin (Long-Acting Insulin) Sales Volume by Application (2018-2023)

    • Table North China Basal Insulin (Long-Acting Insulin) Sales Volume Share by Application (2018-2023)

    • Figure North China Basal Insulin (Long-Acting Insulin) Sales Volume Share by Application (2018-2023)

    • Table Central China Basal Insulin (Long-Acting Insulin) Production Volume by Type (2018-2023)

    • Table Central China Basal Insulin (Long-Acting Insulin) Production Volume Share by Type (2018-2023)

    • Figure Central China Basal Insulin (Long-Acting Insulin) Production Volume Share by Type (2018-2023)

    • Table Central China Basal Insulin (Long-Acting Insulin) Sales Volume by Application (2018-2023)

    • Table Central China Basal Insulin (Long-Acting Insulin) Sales Volume Share by Application (2018-2023)

    • Figure Central China Basal Insulin (Long-Acting Insulin) Sales Volume Share by Application (2018-2023)

    • Table South China Basal Insulin (Long-Acting Insulin) Production Volume by Type (2018-2023)

    • Table South China Basal Insulin (Long-Acting Insulin) Production Volume Share by Type (2018-2023)

    • Figure South China Basal Insulin (Long-Acting Insulin) Production Volume Share by Type (2018-2023)

    • Table South China Basal Insulin (Long-Acting Insulin) Sales Volume by Application (2018-2023)

    • Table South China Basal Insulin (Long-Acting Insulin) Sales Volume Share by Application (2018-2023)

    • Figure South China Basal Insulin (Long-Acting Insulin) Sales Volume Share by Application (2018-2023)

    • Table East China Basal Insulin (Long-Acting Insulin) Production Volume by Type (2018-2023)

    • Table East China Basal Insulin (Long-Acting Insulin) Production Volume Share by Type (2018-2023)

    • Figure East China Basal Insulin (Long-Acting Insulin) Production Volume Share by Type (2018-2023)

    • Table East China Basal Insulin (Long-Acting Insulin) Sales Volume by Application (2018-2023)

    • Table East China Basal Insulin (Long-Acting Insulin) Sales Volume Share by Application (2018-2023)

    • Figure East China Basal Insulin (Long-Acting Insulin) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Basal Insulin (Long-Acting Insulin) Production Volume by Type (2018-2023)

    • Table Northeast China Basal Insulin (Long-Acting Insulin) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Basal Insulin (Long-Acting Insulin) Production Volume Share by Type (2018-2023)

    • Table Northeast China Basal Insulin (Long-Acting Insulin) Sales Volume by Application (2018-2023)

    • Table Northeast China Basal Insulin (Long-Acting Insulin) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Basal Insulin (Long-Acting Insulin) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Basal Insulin (Long-Acting Insulin) Production Volume by Type (2018-2023)

    • Table Southwest China Basal Insulin (Long-Acting Insulin) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Basal Insulin (Long-Acting Insulin) Production Volume Share by Type (2018-2023)

    • Table Southwest China Basal Insulin (Long-Acting Insulin) Sales Volume by Application (2018-2023)

    • Table Southwest China Basal Insulin (Long-Acting Insulin) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Basal Insulin (Long-Acting Insulin) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Basal Insulin (Long-Acting Insulin) Production Volume by Type (2018-2023)

    • Table Northwest China Basal Insulin (Long-Acting Insulin) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Basal Insulin (Long-Acting Insulin) Production Volume Share by Type (2018-2023)

    • Table Northwest China Basal Insulin (Long-Acting Insulin) Sales Volume by Application (2018-2023)

    • Table Northwest China Basal Insulin (Long-Acting Insulin) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Basal Insulin (Long-Acting Insulin) Sales Volume Share by Application (2018-2023)

    • Table Exir Company Profile

    • Table Exir Basal Insulin (Long-Acting Insulin) Revenue, Price and Gross (2018-2023)

    • Table Wockhardt Company Profile

    • Table Wockhardt Basal Insulin (Long-Acting Insulin) Revenue, Price and Gross (2018-2023)

    • Table SEDICO Company Profile

    • Table SEDICO Basal Insulin (Long-Acting Insulin) Revenue, Price and Gross (2018-2023)

    • Table Novo Nordisk AS Company Profile

    • Table Novo Nordisk AS Basal Insulin (Long-Acting Insulin) Revenue, Price and Gross (2018-2023)

    • Table Biocon Company Profile

    • Table Biocon Basal Insulin (Long-Acting Insulin) Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly Company Profile

    • Table Eli Lilly Basal Insulin (Long-Acting Insulin) Revenue, Price and Gross (2018-2023)

    • Table Julphar Company Profile

    • Table Julphar Basal Insulin (Long-Acting Insulin) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US